James W. Vardiman focuses on Pathology, Internal medicine, Leukemia, Myeloid and Immunology. His Pathology study combines topics in areas such as Chemotherapy and Karyotype, Chromosome abnormality. His work deals with themes such as Gastroenterology, Surgery, Oncology and Cytogenetics, which intersect with Internal medicine.
He has researched Leukemia in several fields, including Cancer, Myeloid leukemia, Survival analysis and Bone marrow. The various areas that James W. Vardiman examines in his Myeloid study include Hematopathology and MEDLINE. His Immunology study focuses on Myelodysplastic syndromes in particular.
His scientific interests lie mostly in Pathology, Internal medicine, Leukemia, Immunology and Bone marrow. The study incorporates disciplines such as Myeloid and Karyotype in addition to Pathology. His Myeloid research incorporates themes from Myelofibrosis and Family medicine.
James W. Vardiman has included themes like Gastroenterology, Surgery and Oncology in his Internal medicine study. His studies deal with areas such as Myeloid leukemia, Survival analysis, Chemotherapy and Cytogenetics as well as Leukemia. His study looks at the relationship between Immunology and fields such as Cancer research, as well as how they intersect with chemical problems.
His primary areas of investigation include Internal medicine, Cancer research, Immunology, Myeloid and Pathology. His work deals with themes such as Gastroenterology, Surgery and Oncology, which intersect with Internal medicine. His work on Myelodysplastic syndromes, Acute leukemia and T cell as part of general Immunology study is frequently linked to Chronic eosinophilic leukemia, therefore connecting diverse disciplines of science.
The Acute leukemia study combines topics in areas such as Mast cell leukemia and Intensive care medicine. His studies in Myeloid integrate themes in fields like Myeloproliferative neoplasm and PDGFRB. His Pathology research includes elements of Essential thrombocythemia and MEDLINE.
James W. Vardiman mainly investigates Myeloproliferative neoplasm, Internal medicine, Immunology, Myelofibrosis and Myelodysplastic syndromes. His study explores the link between Myeloproliferative neoplasm and topics such as Myeloid that cross with problems in PDGFRB, Dysplasia, NPM1 and Bone marrow. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Surgery and Oncology.
His study looks at the intersection of Surgery and topics like Leukemia with Cancer. His Myelodysplastic syndromes study is related to the wider topic of Pathology. His Acute leukemia study combines topics from a wide range of disciplines, such as Acute erythroid leukemia and Atypical chronic myeloid leukemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber;Attilio Orazi;Robert Hasserjian;Jürgen Thiele.
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
Nancy Lee Harris;Elaine S. Jaffe;Jacques Diebold;Georges Flandrin.
Journal of Clinical Oncology (1999)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning.
The World Health Organization (WHO) classification of the myeloid neoplasms.
James W. Vardiman;Nancy Lee Harris;Richard D. Brunning.
Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.
A Tefferi;J W Vardiman.
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Peter Valent;Hans P. Horny;Luis Escribano;B. Jack Longley.
Leukemia Research (2001)
The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997
N. L. Harris;E. S. Jaffe;J. Diebold;G. Flandrin.
Annals of Oncology (1999)
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
M M Le Beau;K S Albain;R A Larson;J W Vardiman.
Journal of Clinical Oncology (1986)
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.
Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka.
Absence of the Wild-Type Allele Predicts Poor Prognosis in Adult de Novo Acute Myeloid Leukemia with Normal Cytogenetics and the Internal Tandem Duplication of FLT3 A Cancer and Leukemia Group B Study
Susan P. Whitman;Kellie J. Archer;Lan Feng;Claudia Baldus.
Cancer Research (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: